These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 20381113)
1. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors. Montanari F; O'Connor OA; Savage DG; Zain JM; Venkatraman S; McCormick EK; Crook MT; Tsao L; Sevilla DW; Bhagat G; Alobeid B Hum Pathol; 2010 Aug; 41(8):1150-8. PubMed ID: 20381113 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant. Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151 [TBL] [Abstract][Full Text] [Related]
3. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization. Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332 [TBL] [Abstract][Full Text] [Related]
4. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586 [TBL] [Abstract][Full Text] [Related]
5. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases. Chen W; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Weiss LM; Wang J Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience. Cho MC; Park CJ; Huh J; Chi HS; Jang S; Suh C; Lee KH; Lee JH; Seo JJ; Im HJ Clin Transplant; 2012; 26(4):E381-7. PubMed ID: 22694766 [TBL] [Abstract][Full Text] [Related]
7. Posttransplant lymphoproliferative disorder after liver and kidney transplant. Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813 [TBL] [Abstract][Full Text] [Related]
8. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease. Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050 [TBL] [Abstract][Full Text] [Related]
9. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry. Zimmermann H; Oschlies I; Fink S; Pott C; Neumayer HH; Lehmkuhl H; Hauser IA; Dreyling M; Kneba M; Gärtner B; Anagnostopoulos I; Riess H; Klapper W; Trappe RU Transplantation; 2012 Mar; 93(5):543-50. PubMed ID: 22234349 [TBL] [Abstract][Full Text] [Related]
10. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children. Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052 [TBL] [Abstract][Full Text] [Related]
11. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial. Blaes AH; Peterson BA; Bartlett N; Dunn DL; Morrison VA Cancer; 2005 Oct; 104(8):1661-7. PubMed ID: 16149091 [TBL] [Abstract][Full Text] [Related]
12. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Johnson LR; Nalesnik MA; Swerdlow SH Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518 [TBL] [Abstract][Full Text] [Related]
13. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution. Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848 [TBL] [Abstract][Full Text] [Related]
14. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival. Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103 [TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities. Djokic M; Le Beau MM; Swinnen LJ; Smith SM; Rubin CM; Anastasi J; Carlson KM Genes Chromosomes Cancer; 2006 Mar; 45(3):313-8. PubMed ID: 16283619 [TBL] [Abstract][Full Text] [Related]
16. Monomorphic Epstein-Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient. Bruce AJ; Subtil A; Rogers RS; Castro LA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):e24-8. PubMed ID: 16997090 [TBL] [Abstract][Full Text] [Related]
17. Posttransplant lymphoproliferative disorders in transplant recipients. Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study. Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954 [TBL] [Abstract][Full Text] [Related]
19. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties. Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694 [TBL] [Abstract][Full Text] [Related]
20. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]